Abstract:Key PointsThe assembly of a functional vascular system requires coordinated signalling between various growth factors and receptors. The Tie receptors and their angiopoietin (Ang) ligands have important functions during embryonic vessel assembly and maturation and control adult vascular homeostasis.ANG1 and TIE2-deficiency in mice lead to lethality at embryonic day 10.5 (E10.5) as a consequence of perturbed vessel organization and maturation. TIE1-deficient mice have no overt angiogenesis-related phenotype but die in late gestation as a consequence of widespread oedema and haemorrhage. ANG2 is dispensable for embryonic development, but mice that overexpress ANG2 have essentially the same phenotypes as ANG1- and TIE2-deficient mice.Constitutive stimulation of TIE2 by ANG1 leads to vessel maturation and contributes to the maintenance of vascular quiescence. Vascular quiescence is associated with the recruitment of peri-endothelial cells (pericytes and smooth muscle cells).TIE2 activation drives several signalling pathways. The dominant signalling pathway is the phosphoinositide 3-kinase (PI3K)–AKT pathway, which transduces survival signals.The antagonist of constitutive ANG1–TIE2 signalling, ANG2, is produced and stored by endothelial cells (ECs). It acts through an autocrine-loop mechanism to control EC responsiveness to multiple cytokines, which include angiogenesis-inducing cytokines, such as vascular endothelial growth factor (VEGF), permeability-inducing molecules, such as histamine and bradykinin, and inflammation-inducing factors, such as tumour-necrosis factor-α (TNFα).TIE1 is an orphan receptor of which the mechanism of action has not been uncovered. An emerging concept suggests that TIE1–TIE2 heterodimerization might contribute to TIE2 signal transduction.Non-vascular functions of Ang–Tie signalling are only recently being uncovered. Most notably, ANG1–TIE2 signalling has a crucial role in maintaining the haematopoietic stem cell niche.

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system